We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
76
Moderna
MRNA
$21.5B
$42.5M 0.31%
350,139
-58,055
-14% -$7.74M
MRVL icon
77
Marvell Technology
MRVL
$174B
$41.7M 0.3%
697,858
-181,670
-21% -$8.83M
NBIX icon
78
Neurocrine Biosciences
NBIX
$17.7B
$41.5M 0.3%
440,416
+23,236
+6% +$2.27M
TTEK icon
79
Tetra Tech
TTEK
$8.23B
$41.1M 0.3%
1,255,770
-93,435
-7% -$2.75M
CTAS icon
80
Cintas
CTAS
$82.4B
$40.6M 0.29%
326,692
-68,572
-17% -$8.05M
TJX icon
81
TJX Companies
TJX
$170B
$40.5M 0.29%
477,833
-15,784
-3% -$1.25M
TXN icon
82
Texas Instruments
TXN
$255B
$40.4M 0.29%
224,458
-114,138
-34% -$19.6M
KEYS icon
83
Keysight
KEYS
$54.5B
$39.8M 0.29%
237,421
+23,626
+11% +$3.67M
LNTH icon
84
Lantheus
LNTH
$6.82B
$39.7M 0.29%
473,474
+58,265
+14% +$5.23M
MS icon
85
Morgan Stanley
MS
$337B
$39.4M 0.28%
460,998
-75,273
-14% -$6.44M
CAT icon
86
Caterpillar
CAT
$409B
$39.2M 0.28%
159,405
+26,858
+20% +$5.99M
EL icon
87
Estee Lauder
EL
$29B
$39.2M 0.28%
199,513
+72,189
+57% +$15.3M
SYK icon
88
Stryker
SYK
$127B
$38.4M 0.28%
125,768
-29,718
-19% -$8.58M
DIS icon
89
Walt Disney
DIS
$165B
$37.7M 0.27%
422,187
-290,077
-41% -$27.5M
CL icon
90
Colgate-Palmolive
CL
$72.6B
$37.1M 0.27%
481,455
-50,490
-9% -$3.91M
ZTO icon
91
ZTO Express
ZTO
$18.2B
$36.9M 0.27%
1,472,110
-155,120
-10% -$4.27M
BMRN icon
92
BioMarin Pharmaceuticals
BMRN
$11.5B
$36.2M 0.26%
418,027
-137,428
-25% -$12.9M
NEE icon
93
NextEra Energy
NEE
$187B
$36.1M 0.26%
486,907
+4,182
+0.9% +$317K
CMCSA icon
94
Comcast
CMCSA
$79.1B
$34.9M 0.25%
840,348
-206,613
-20% -$8.21M
BIO icon
95
Bio-Rad Laboratories Class A
BIO
$8.42B
$34.9M 0.25%
91,991
+7,916
+9% +$3.22M
SBUX icon
96
Starbucks
SBUX
$118B
$34.8M 0.25%
351,516
-70,830
-17% -$7.35M
BALL icon
97
Ball Corp
BALL
$17B
$34.7M 0.25%
596,873
-65,832
-10% -$3.57M
VEEV icon
98
Veeva Systems
VEEV
$30.3B
$34.7M 0.25%
175,504
-31,784
-15% -$5.8M
XOM icon
99
ExxonMobil
XOM
$651B
$34.4M 0.25%
320,548
+8,932
+3% +$975K
UDR icon
100
UDR
UDR
$12.9B
$34.1M 0.25%
794,142
-105,584
-12% -$4.34M
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.